Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis

被引：0
|
作者：
T. Sugimoto
T. Nakamura
Y. Nakamura
Y. Isogai
M. Shiraki
机构：
[1] Shimane University,Internal Medicine 1, Faculty of Medicine
[2] National Center for Global Health and Medicine,Project for Bone Metabolic Disease
[3] Asahi Kasei Pharma Corporation,undefined
[4] Research Institute and Practice for Involutional Diseases,undefined
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Bone formation; Bone resorption; Calcium metabolism; Human; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1173 / 1180
页数：7
相关论文
共 35 条
  • [1] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    Sugimoto, T.
    Nakamura, T.
    Nakamura, Y.
    Isogai, Y.
    Shiraki, M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1173 - 1180
  • [2] Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    T. Kawada
    Osteoporosis International, 2014, 25 : 2321 - 2321
  • [3] Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
    T. Sugimoto
    T. Nakamura
    Y. Nakamura
    Y. Isogai
    M. Shiraki
    Osteoporosis International, 2014, 25 : 2323 - 2324
  • [4] Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
    M. Shiraki
    T. Sugimoto
    T. Nakamura
    Osteoporosis International, 2013, 24 : 219 - 226
  • [5] Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
    Shiraki, M.
    Sugimoto, T.
    Nakamura, T.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) : 219 - 226
  • [6] Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
    Tanaka, Shiro
    Kuroda, Tatsuhiko
    Sugimoto, Toshitsugu
    Nakamura, Toshitaka
    Shiraki, Masataka
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 931 - 936
  • [7] Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis
    Recker, Robert R.
    Marin, Fernando
    Ish-Shalom, Sophia
    Moericke, Ruediger
    Hawkins, Federico
    Kapetanos, Georgios
    de la Pena, Maria P.
    Kekow, Joern
    Farrerons, Jordi
    Sanz, Beatriz
    Oertel, Heide
    Stepan, Jan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (08) : 1358 - 1368
  • [8] Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
    Chen, PQ
    Satterwhite, JH
    Licata, AA
    Lewiecki, EM
    Sipos, AA
    Misurski, DM
    Wagman, RB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (06) : 962 - 970
  • [9] The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk
    Sone, Teruki
    Ito, Masako
    Fukunaga, Masao
    Tomomitsu, Tatsushi
    Sugimoto, Toshitsugu
    Shiraki, Masataka
    Yoshimura, Takeshi
    Nakamura, Toshitaka
    BONE, 2014, 64 : 75 - 81
  • [10] Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study
    Kumagai, Yuji
    Ose, Atsushi
    Tanaka, Kosuke
    Sugimoto, Toshitsugu
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (01): : 87 - 96
1234